Co-Authors
This is a "connection" page, showing publications co-authored by Félix Gutiérrez and Vanesa Agulló.
Connection Strength
2.195
-
Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study. J Infect. 2021 05; 82(5):186-230.
Score: 0.918
-
Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study. J Autoimmun. 2021 09; 123:102703.
Score: 0.239
-
Performance of Saliva Specimens for the Molecular Detection of SARS-CoV-2 in the Community Setting: Does Sample Collection Method Matter? J Clin Microbiol. 2021 03 19; 59(4).
Score: 0.234
-
Nasopharyngeal Panbio COVID-19 Antigen Performed at Point-of-Care Has a High Sensitivity in Symptomatic and Asymptomatic Patients With Higher Risk for Transmission and Older Age. Open Forum Infect Dis. 2021 Mar; 8(3):ofab059.
Score: 0.232
-
SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response. Open Forum Infect Dis. 2021 Feb; 8(2):ofab005.
Score: 0.231
-
Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study. EBioMedicine. 2020 Oct; 60:102999.
Score: 0.226
-
Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study. J Clin Immunol. 2021 10; 41(7):1490-1501.
Score: 0.060
-
Preemptive interleukin-6 blockade in patients with COVID-19. Sci Rep. 2020 10 08; 10(1):16826.
Score: 0.057